{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T20:51:25Z","timestamp":1769979085089,"version":"3.49.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T00:00:00Z","timestamp":1611878400000},"content-version":"vor","delay-in-days":150,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005616","name":"Allergan Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005616","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.bmc.2020.115659","type":"journal-article","created":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T21:17:36Z","timestamp":1595452656000},"page":"115659","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Synthesis and activity of isoleucine sulfonamide derivatives as novel botulinum neurotoxin serotype A light chain inhibitors"],"prefix":"10.1016","volume":"28","author":[{"given":"Jordan C.","family":"Thompson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy T.","family":"Dao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Ku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra L.","family":"Rodriguez-Beltran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Amezcua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandra Y.","family":"Palomino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thanh","family":"Lien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas T.","family":"Salzameda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2020.115659_b0005","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.285.8.1059","article-title":"Botulinum toxin as a biological weapon: Medical and public health management","volume":"285","author":"Arnon","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.bmc.2020.115659_b0010","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1007\/s00018-006-6308-z","article-title":"Bioterrorism: Management of major biological agents Cellular and molecular life sciences","volume":"63","author":"Bossi","year":"2006","journal-title":"CMLS"},{"key":"10.1016\/j.bmc.2020.115659_b0015","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1128\/mr.46.1.86-94.1982","article-title":"Bacterial toxins: A table of lethal amounts","volume":"46","author":"Gill","year":"1982","journal-title":"Microbiol Rev"},{"key":"10.1016\/j.bmc.2020.115659_b0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/10408410590912952","article-title":"Clostridium botulinum: A bug with beauty and weapon","volume":"31","author":"Shukla","year":"2005","journal-title":"Crit Rev Microbiol"},{"key":"10.1016\/j.bmc.2020.115659_b0025","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1124\/pr.116.012658","article-title":"Botulinum Neurotoxins: Biology, pharmacology, and toxicology","volume":"69","author":"Pirazzini","year":"2017","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.bmc.2020.115659_b0030","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.toxicon.2012.11.011","article-title":"Botulinum neurotoxins: Mechanism of action","volume":"67","author":"Tighe","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.bmc.2020.115659_b0035","doi-asserted-by":"crossref","first-page":"23479","DOI":"10.1016\/S0021-9258(18)35863-0","article-title":"Botulinum neurotoxins are zinc proteins","volume":"267","author":"Schiavo","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2020.115659_b0040","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/0041-0101(92)90525-A","article-title":"A zinc-protease specific domain in botulinum and tetanus neurotoxins","volume":"30","author":"Fujii","year":"1992","journal-title":"Toxicon"},{"key":"10.1016\/j.bmc.2020.115659_b0045","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.neuron.2013.10.022","article-title":"Neurotransmitter release: The last millisecond in the life of a synaptic vesicle","volume":"80","author":"S\u00fcdhof","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.bmc.2020.115659_b0050","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1021\/cb600179d","article-title":"The use of small molecules to investigate molecular mechanisms and therapeutic targets for treatment of botulinum neurotoxin A intoxication","volume":"1","author":"Dickerson","year":"2006","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.bmc.2020.115659_b0055","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1021\/acs.accounts.9b00261","article-title":"Strategies to counteract botulinum neurotoxin A: Nature's deadliest biomolecule","volume":"52","author":"Lin","year":"2019","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.bmc.2020.115659_b0060","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.toxicon.2009.03.016","article-title":"Investigations into small molecule non-peptidic inhibitors of the botulinum neurotoxins","volume":"54","author":"\u010capkov\u00e1","year":"2009","journal-title":"Toxicon"},{"key":"10.1016\/j.bmc.2020.115659_b0065","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2174\/1568026615666150309150338","article-title":"Recent developments with metalloprotease inhibitor class of drug candidates for botulinum neurotoxins","volume":"15","author":"Kumar","year":"2015","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.bmc.2020.115659_b0070","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1039\/C4MD00053F","article-title":"Discovery and SAR study of a sulfonamide hydroxamic acid inhibitor for the botulinum neurotoxin serotype A light chain","volume":"5","author":"Burtea","year":"2014","journal-title":"Med Chem Comm"},{"key":"10.1016\/j.bmc.2020.115659_b0075","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.1021\/bi2001483","article-title":"Structural characterization of three novel hydroxamate-based zinc chelating inhibitors of the Clostridium botulinum serotype A neurotoxin light chain metalloprotease reveals a compact binding site resulting from 60\/70 loop flexibility","volume":"50","author":"Thompson","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmc.2020.115659_b0080","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.chembiol.2007.03.014","article-title":"Structures of Clostridium botulinum Neurotoxin Serotype A Light Chain complexed with small-molecule inhibitors highlight active-site flexibility","volume":"14","author":"Silvaggi","year":"2007","journal-title":"Chem Biol"},{"key":"10.1016\/j.bmc.2020.115659_b0085","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.toxicon.2017.06.016","article-title":"Small molecule metalloprotease inhibitor with in vitro, ex vivo and in vivo efficacy against botulinum neurotoxin serotype A","volume":"137","author":"Jacobson","year":"2017","journal-title":"Toxicon"},{"key":"10.1016\/j.bmc.2020.115659_b0090","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.bmcl.2016.11.019","article-title":"A matrix-focused structure-activity and binding site flexibility study of quinolinol inhibitors of botulinum neurotoxin serotype A","volume":"27","author":"Harrell","year":"2017","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2020.115659_b0095","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.bmc.2013.11.053","article-title":"Synthesis\/biological evaluation of hydroxamic acids and their prodrugs as inhibitors for Botulinum neurotoxin A light chain","volume":"22","author":"Seki","year":"2014","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2020.115659_b0100","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.bmc.2012.12.001","article-title":"Evaluation of adamantane hydroxamates as botulinum neurotoxin inhibitors: Synthesis, crystallography, modeling, kinetic and cellular based studies","volume":"21","author":"\u0160ilh\u00e1r","year":"2013","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2020.115659_b0105","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ejmech.2012.03.043","article-title":"The synthesis of 2,5-bis(4-amidinophenyl)thiophene derivatives providing submicromolar-range inhibition of the botulinum neurotoxin serotype A metalloprotease","volume":"53","author":"Opsenica","year":"2012","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2020.115659_b0110","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2174\/092986708783497300","article-title":"Role of sulfonamide group in matrix metalloproteinase inhibitors","volume":"15","author":"Cheng","year":"2008","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bmc.2020.115659_b0115","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/j.bmc.2007.01.011","article-title":"Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs","volume":"15","author":"Verma","year":"2007","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2020.115659_b0120","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.2174\/0929867023369402","article-title":"Hydroxamic acids as pharmacological agents","volume":"9","author":"Muri","year":"2002","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bmc.2020.115659_b0125","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1016\/j.bmcl.2009.03.056","article-title":"Synthesis and biological evaluation of ((4-keto)-phenoxy)methyl biphenyl-4-sulfonamides: a class of potent aggrecanase-1 inhibitors","volume":"19","author":"Hopper","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2020.115659_b0130","doi-asserted-by":"crossref","first-page":"6463","DOI":"10.1016\/j.bmcl.2007.09.103","article-title":"Synthesis and structure-activity relationships of second-generation hydroxamate botulinum neurotoxin A protease inhibitors","volume":"17","author":"Capkova","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2020.115659_b0135","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1021\/cc060010h","article-title":"Synthesis, characterization and development of a high-throughput methodology for the discovery of botulinum neurotoxin a inhibitors","volume":"8","author":"Boldt","year":"2006","journal-title":"J Comb Chem"},{"key":"10.1016\/j.bmc.2020.115659_b0140","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1021\/ol902820z","article-title":"Chirality holds the key for potent inhibition of the botulinum neurotoxin serotype a protease","volume":"12","author":"Stowe","year":"2010","journal-title":"Org Lett"},{"key":"10.1016\/j.bmc.2020.115659_b0145","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1021\/ol0603211","article-title":"Identification of a potent botulinum neurotoxin a protease inhibitor using in situ lead identification chemistry","volume":"8","author":"Boldt","year":"2006","journal-title":"Org Lett"},{"key":"10.1016\/j.bmc.2020.115659_b0150","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/med.20068","article-title":"Therapeutic potential of sulfamides as enzyme inhibitors","volume":"26","author":"Winum","year":"2006","journal-title":"Med Res Rev"},{"key":"10.1016\/j.bmc.2020.115659_b0155","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J Comput Chem"},{"key":"10.1016\/j.bmc.2020.115659_b0160","doi-asserted-by":"crossref","first-page":"5004","DOI":"10.1074\/jbc.M608166200","article-title":"Inhibition of metalloprotease botulinum serotype a from a pseudo-peptide binding mode to a small molecule that is active in primary neurons","volume":"282","author":"Burnett","year":"2007","journal-title":"J Biol Chem"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089620304892?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089620304892?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:08:10Z","timestamp":1760836090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089620304892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":32,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0968089620304892"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2020.115659","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and activity of isoleucine sulfonamide derivatives as novel botulinum neurotoxin serotype A light chain inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2020.115659","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"115659"}}